Researchers at MIT and other institutions have identified compounds that can fight off viral infection by activating a ...

A cancer-killing virus could soon be approved for use after shrinking tumours in a third of people with late-stage melanoma ...

Scientists are developing all sorts of potential new treatments to tackle the most difficult cancer cases—including some that ...

A cold sore might seem like a minor nuisance. But behind that tingling lip is one of the world’s most widespread and cunning viruses—herpes simplex virus type 1, or HSV-1. It infects billions of ...

University of Southern California researchers have found a way to rebrand this oft-embarrassing sore subject by genetically modifying HSV-1 and administering it to patients with treatment-resistant, ...

A new study finds that prior herpesvirus infections are linked to a faster age-related increase in blood biomarkers ...

Findings from a recent study suggest that the herpes virus can be modified into an effective treatment for some types of advanced melanoma. Conducte ...

Over 800 million people have genital herpes — and in many cases the virus can flare up over a person's lifetime, causing painful symptoms. So why doesn't the world pay more attention?

Herpes simplex virus 2, the sexually transmitted disease, infects more than a quarter of people by their forties, the CDC says. While anti-viral medications can help, there is no cure for herpes ...

An image of the human herpes virus, HSV, taken with transmission electron microscope. Two types can cause genital herpes: HSV-1 and HSV-2.

The U.S. Food and Drug Administration approved a pre-filled syringe version of GSK's blockbuster shingles vaccine Shingrix, ...

As many as 3.7 billion people under the age of 50, an estimated 67 percent of the world's population, have the herpes simplex virus type 1 (HSV-1), according to the World Health Organization.